ANNOUNCEMENT 31 May 2017

On 31 May 2017, the EIB provided financing worth EUR 20 million (USD 22 million).

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

EIB, Project financing summary, 'Stat-Diagnostica Diagcore (Idff)', 31 May 2017.
https://www.eib.org/en/projects/loans/all/20150659

EIB, Financed projects list
https://www.eib.org/en/projects/pipelines/index.htm?q=&sortColumn=projectStatusDate&sortDir=desc&pageNumber=0&itemPerPage=25&pageable=true&language=EN&defaultLanguage=EN&yearFrom=2017&yearTo=2017&orCountries.region=true&orCountries=true&orSectors=true&orStatus=true

European Investment Bank. Press release. Spain: EUR 20 million EIB loan facility under the InnovFin programme to support medical diagnostics innovation in Spain.
https://www.eib.org//en/press/all/2017-132-eur-20-million-eib-loan-facility-under-the-innovfin-programme-to-support-medical-diagnostics-innovation-in-spain

Inception date: 31 May 2017 | Removal date: open ended

State loan

On 31 May 2017, the European Investment Bank (EIB) announced an agreement worth EUR 20 million (approx. USD 22 million) for the project Stat-Diagnostica Diagcore (Idff) from Spain.

According to the project description issued by the EIB, Financing the remaining R&D and market launch of diacore, a near-patient Infectious Disease IVD diagnostics device.

A state act in the GTA database is assessed solely in terms of the extent to which its implementation affects foreign commercial interests. On this metric, the investment support granted here is discriminatory.

AFFECTED SECTORS

 
482

AFFECTED PRODUCTS

 
902780